News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Emma Lawrence, MD

Advertisement

Articles by Emma Lawrence, MD

VTE

Progestins for AUB in women at risk of VTE

ByEmma Lawrence, MD,Elisabeth Quint, MD,Angela C. Weyand, MD
February 10th 2020

These four patient cases can help improve your decision-making about the best hormonal regimen for this population.

Advertisement

Latest Updated Articles

  • VTE
    Progestins for AUB in women at risk of VTE

    Published: February 10th 2020 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

DARE to PLAY sildenafil cream becomes commercially available for women in select states

2

High costs and transfusions linked to acute heavy menstrual bleeding

3

George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia

4

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

5

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us